TV is poised for a structural re-rating and outsized upside in FY 2026. Click here to find out why FUBO stock is a Strong Buy ...

OnCusp Therapeutics Announces Encouraging Initial Phase 1a Results from Ongoing First-in-Human Study Evaluating its ...

India's equity market is rebounding due to easing geopolitical tensions, strong earnings, and investor inflows. IPO momentum ...

Anand Shah of ICICI Prudential AMC discusses their successful PIPE and Value strategies, which have achieved impressive CAGR ...

Agilent's Morningstar Uncertainty Rating remains Medium, thanks to its sticky end markets that should result in relatively steady demand trends in the long run, despite its dependence on one-time ...

Adriana Tullman of Peak Altitude Partners discusses how the firm distinguishes itself from other alternative investment offerings.

Buffer strategies have experienced notable investor interest amid the 2025 bout of equity market volatility. Click to read.

Fabrix.ai’s intelligent agents take over repetitive, time-consuming operational workloads for its enterprise customers, ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

While Indian banks are benefitting from emerging trends like mutual fund distribution and insurance sales, much of the fee ...

Background A 55-year-old male was diagnosed with poorly differentiated thyroid cancer after total thyroidectomy, which was performed because of progressive enlargement of a dominant thyroid nodule.